GRAS Notice for Pichia Kudriavzevii ASCUSDY21 for Use As a Direct Fed Microbial in Dairy Cattle

Total Page:16

File Type:pdf, Size:1020Kb

GRAS Notice for Pichia Kudriavzevii ASCUSDY21 for Use As a Direct Fed Microbial in Dairy Cattle GRAS Notice for Pichia kudriavzevii ASCUSDY21 for Use as a Direct Fed Microbial in Dairy Cattle Prepared for: Division of Animal Feeds, (HFV-220) Center for Veterinary Medicine 7519 Standish Place Rockville, Maryland 20855 Submitted by: ASCUS Biosciences, Inc. 6450 Lusk Blvd Suite 209 San Diego, California 92121 GRAS Notice for Pichia kudriavzevii ASCUSDY21 for Use as a Direct Fed Microbial in Dairy Cattle TABLE OF CONTENTS PART 1 – SIGNED STATEMENTS AND CERTIFICATION ................................................................................... 9 1.1 Name and Address of Organization .............................................................................................. 9 1.2 Name of the Notified Substance ................................................................................................... 9 1.3 Intended Conditions of Use .......................................................................................................... 9 1.4 Statutory Basis for the Conclusion of GRAS Status ....................................................................... 9 1.5 Premarket Exception Status .......................................................................................................... 9 1.6 Availability of Information .......................................................................................................... 10 1.7 Freedom of Information Act, 5 U.S.C. 552 .................................................................................. 10 1.8 Certification ................................................................................................................................. 10 PART 2 – IDENTITY, METHOD OF MANUFACTURE, SPECIFICATIONS AND PHYSICAL OR TECHNICAL EFFECT ............................................................................................................. 11 2.1 Identity ........................................................................................................................................ 11 2.1.1 Taxonomic Classification ..................................................................................................... 11 2.1.2 Source of the Microorganism ............................................................................................. 11 2.1.3 Description of the Microorganism ...................................................................................... 11 2.1.4 Identification of the Microorganism ................................................................................... 13 2.1.4.1 Ribosomal DNA Marker Analysis ..................................................................................... 13 2.1.4.2 Whole Genome Sequence Analysis and Annotation ...................................................... 14 2.1.4.3 Whole Genome Sequence Comparison .......................................................................... 14 2.1.4.4 Section Summary ............................................................................................................ 15 2.1.5 Plasmid Analysis .................................................................................................................. 15 2.1.6 In-vitro and In-silico Analysis of Antimicrobial Susceptibility ............................................. 15 2.1.6.1 Section Summary ............................................................................................................ 16 2.1.7 Antimicrobial Production .................................................................................................... 17 2.1.8 Toxigenicity and Pathogenicity ........................................................................................... 17 2.1.8.1 Section Summary ............................................................................................................ 22 2.1.9 Genetic Stability .................................................................................................................. 23 2.1.10 Summary of Organism Safety Based on Genomics ............................................................. 23 2 2.2 Method of Manufacture ............................................................................................................. 23 2.2.1 Raw Materials and Processing Aids .................................................................................... 23 2.2.2 Manufacturing Process ....................................................................................................... 23 2.2.3 Production Controls ............................................................................................................ 24 2.3 Product Specifications and Batch Analyses ................................................................................ 25 2.3.1 Product Specifications for Freeze Dried P. kudriavzevii ASCUSDY21 (Notified Substance) ........................................................................................................... 25 2.3.2 Batch Analyses for Freeze Dried P. kudriavzevii ASCUSDY21 (Notified Substance) .......................................................................................................................... 25 2.3.3 Product Specifications for the Fat Encapsulated Product ................................................... 25 2.3.4 Batch Analyses for Fat Encapsulated Product..................................................................... 26 2.3.5 Additional Analytical Data ................................................................................................... 26 2.4 Stability ....................................................................................................................................... 26 2.4.1 Stability Data ....................................................................................................................... 26 2.4.1.1 Stability Study at 5°C ....................................................................................................... 27 2.1.4.2 Stability Study at 25°C ..................................................................................................... 27 2.1.4.3 Stability Study at 40°C ..................................................................................................... 28 2.4.2 In-Feed Stability .................................................................................................................. 28 2.4.3 Homogeneity Data .............................................................................................................. 28 2.4.4 Manufacturing Summary .................................................................................................... 29 2.5 Effect of the Notified Substance ................................................................................................. 29 2.5.1 Rumen Microbiome ............................................................................................................ 30 2.5.2 Impact of Failure of the Notified Substance ....................................................................... 31 2.5.3 Summary ............................................................................................................................. 34 PART 3 – TARGET ANIMAL AND HUMAN EXPOSURE .................................................................................. 35 3.1 Target Animal Exposure .............................................................................................................. 35 3.1.1 Exposure to the Direct Fed Microbial Strain ....................................................................... 35 3.1.2 Exposure to the Other Components of the Fat Encapsulated Product .............................. 35 3.1.3 Background Exposure to the Microorganism ..................................................................... 36 3.2 Human Exposure ......................................................................................................................... 36 PART 4 – SELF-LIMITING LEVELS OF USE ..................................................................................................... 37 PART 5 – EVIDENCE BASED ON COMMON USE BEFORE 1958 .................................................................... 38 3 PART 6 – NARRATIVE ................................................................................................................................... 39 6.1 Functionality ............................................................................................................................... 39 6.2 Identity ........................................................................................................................................ 41 6.3 Literature Search ......................................................................................................................... 41 6.4 Natural Occurrence ..................................................................................................................... 41 6.4.1 Prevalence in Animals ......................................................................................................... 41 6.4.2 Microbiome Safety .............................................................................................................. 42 6.4.3 Environmental Occurrence ................................................................................................. 43 6.4.4 Section Summary ................................................................................................................ 43 6.5 History of Use in Manufacture of Food and Feed Ingredients
Recommended publications
  • Development and Evaluation of Rrna Targeted in Situ Probes and Phylogenetic Relationships of Freshwater Fungi
    Development and evaluation of rRNA targeted in situ probes and phylogenetic relationships of freshwater fungi vorgelegt von Diplom-Biologin Christiane Baschien aus Berlin Von der Fakultät III - Prozesswissenschaften der Technischen Universität Berlin zur Erlangung des akademischen Grades Doktorin der Naturwissenschaften - Dr. rer. nat. - genehmigte Dissertation Promotionsausschuss: Vorsitzender: Prof. Dr. sc. techn. Lutz-Günter Fleischer Berichter: Prof. Dr. rer. nat. Ulrich Szewzyk Berichter: Prof. Dr. rer. nat. Felix Bärlocher Berichter: Dr. habil. Werner Manz Tag der wissenschaftlichen Aussprache: 19.05.2003 Berlin 2003 D83 Table of contents INTRODUCTION ..................................................................................................................................... 1 MATERIAL AND METHODS .................................................................................................................. 8 1. Used organisms ............................................................................................................................. 8 2. Media, culture conditions, maintenance of cultures and harvest procedure.................................. 9 2.1. Culture media........................................................................................................................... 9 2.2. Culture conditions .................................................................................................................. 10 2.3. Maintenance of cultures.........................................................................................................10
    [Show full text]
  • The Role and Use of Non-Saccharomyces Yeasts in Wine Production
    The Role and Use of Non-Saccharomyces Yeasts in Wine Production N.P. Jolly1*, O.P.H. Augustyn1 and I.S. Pretorius2** (1) ARC Infruitec-Nietvoorbij***, Private Bag X5026, 7599 Stellenbosch, South Africa. (2) Institute for Wine Biotechnology, Department of Viticulture & Oenology, Stellenbosch University, Private Bag X1, 7602 Matieland (Stellenbosch), South Africa. Submitted for publication: September 2005 Accepted for publication: April 2006 Key words: Non-Saccharomyces, yeasts, vineyards, cellars, fermentation, wine. The contribution by the numerous grape-must-associated non-Saccharomyces yeasts to wine fermentation has been debated extensively. These yeasts, naturally present in all wine fermentations, are metabolically active and their metabolites can impact on wine quality. Although often seen as a source of microbial spoilage, there is substantial contrary evidence pointing to a positive contribution by these yeasts. The role of non-Saccharomyces yeasts in wine fermentation is therefore receiving increasing attention by wine microbiologists in Old and New World wine producing countries. Species that have been investigated for wine production thus far include those from the Candida, Kloeckera, Hanseniaspora, Zygosaccharomyces, Schizosaccharomyces, Torulaspora, Brettanomyces, Saccharomycodes, Pichia and Williopsis genera. In this review the use and role of non-Saccharomyces yeast in wine production is presented and research trends are discussed. INTRODUCTION roles of the numerous non-Saccharomyces yeasts normally asso- ciated with grape must and wine. These yeasts, naturally present Wine is the product of a complex biological and biochemical in all wine fermentations to a greater or lesser extent, are meta- interaction between grapes (grape juice) and different microor- bolically active and their metabolites can impact on wine quality.
    [Show full text]
  • Genome Diversity and Evolution in the Budding Yeasts (Saccharomycotina)
    | YEASTBOOK GENOME ORGANIZATION AND INTEGRITY Genome Diversity and Evolution in the Budding Yeasts (Saccharomycotina) Bernard A. Dujon*,†,1 and Edward J. Louis‡,§ *Department Genomes and Genetics, Institut Pasteur, Centre National de la Recherche Scientifique UMR3525, 75724-CEDEX15 Paris, France, †University Pierre and Marie Curie UFR927, 75005 Paris, France, ‡Centre for Genetic Architecture of Complex Traits, and xDepartment of Genetics, University of Leicester, LE1 7RH, United Kingdom ORCID ID: 0000-0003-1157-3608 (E.J.L.) ABSTRACT Considerable progress in our understanding of yeast genomes and their evolution has been made over the last decade with the sequencing, analysis, and comparisons of numerous species, strains, or isolates of diverse origins. The role played by yeasts in natural environments as well as in artificial manufactures, combined with the importance of some species as model experimental systems sustained this effort. At the same time, their enormous evolutionary diversity (there are yeast species in every subphylum of Dikarya) sparked curiosity but necessitated further efforts to obtain appropriate reference genomes. Today, yeast genomes have been very informative about basic mechanisms of evolution, speciation, hybridization, domestication, as well as about the molecular machineries underlying them. They are also irreplaceable to investigate in detail the complex relationship between genotypes and phenotypes with both theoretical and practical implications. This review examines these questions at two distinct levels offered by the broad evolutionary range of yeasts: inside the best-studied Saccharomyces species complex, and across the entire and diversified subphylum of Saccharomycotina. While obviously revealing evolutionary histories at different scales, data converge to a remarkably coherent picture in which one can estimate the relative importance of intrinsic genome dynamics, including gene birth and loss, vs.
    [Show full text]
  • Expanding the Knowledge on the Skillful Yeast Cyberlindnera Jadinii
    Journal of Fungi Review Expanding the Knowledge on the Skillful Yeast Cyberlindnera jadinii Maria Sousa-Silva 1,2 , Daniel Vieira 1,2, Pedro Soares 1,2, Margarida Casal 1,2 and Isabel Soares-Silva 1,2,* 1 Centre of Molecular and Environmental Biology (CBMA), Department of Biology, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal; [email protected] (M.S.-S.); [email protected] (D.V.); [email protected] (P.S.); [email protected] (M.C.) 2 Institute of Science and Innovation for Bio-Sustainability (IB-S), University of Minho, 4710-057 Braga, Portugal * Correspondence: [email protected]; Tel.: +351-253601519 Abstract: Cyberlindnera jadinii is widely used as a source of single-cell protein and is known for its ability to synthesize a great variety of valuable compounds for the food and pharmaceutical industries. Its capacity to produce compounds such as food additives, supplements, and organic acids, among other fine chemicals, has turned it into an attractive microorganism in the biotechnology field. In this review, we performed a robust phylogenetic analysis using the core proteome of C. jadinii and other fungal species, from Asco- to Basidiomycota, to elucidate the evolutionary roots of this species. In addition, we report the evolution of this species nomenclature over-time and the existence of a teleomorph (C. jadinii) and anamorph state (Candida utilis) and summarize the current nomenclature of most common strains. Finally, we highlight relevant traits of its physiology, the solute membrane transporters so far characterized, as well as the molecular tools currently available for its genomic manipulation.
    [Show full text]
  • Austin Ultrahealth Yeast-Free Protocol 1
    1 01/16/12/ Austin UltraHealth Yeast-Free Protocol 1. Follow the Yeast Diet in your binder for 6 weeks or you may also use recipes from the Elimination Diet. (Just decrease the amount of grains and fruits allowed). 2. You will be taking one pill of prescription antifungal daily, for 30 days. This should always be taken two hours away from your probiotics. This medication can be very hard on your liver so it is important to refrain from ALL alcohol while taking this medication. Candida Die-Off Some patients experience die-off symptoms while eliminating the yeast, or Candida, in their gut. Die off symptoms can include the following: Brain fog Dizziness Headache Floaters in the eyes Anxiety/Irritability Gas, bloating and/or flatulence Diarrhea or constipation Joint/muscle pain General malaise or exhaustion What Causes Die-Off Symptoms? The Candida “die-off” occurs when excess yeast in the body literally dies off. When this occurs, the dying yeasts produce toxins at a rate too fast for your body to process and eliminate. While these toxins are not lethal to the system, they can cause an increase in the symptoms you might already have been experiencing. As the body works to detoxify, those Candida die-off symptoms can emerge and last for a matter of days, or weeks. The two main factors which cause the unpleasant symptoms of Candida die off are dietary changes and antifungal treatments, both of which you will be doing. Dietary Changes: When you begin to make healthy changes in your diet, you begin to starve the excess yeasts that have been hanging around, using up the extra sugars in your blood.
    [Show full text]
  • Candida Auris
    microorganisms Review Candida auris: Epidemiology, Diagnosis, Pathogenesis, Antifungal Susceptibility, and Infection Control Measures to Combat the Spread of Infections in Healthcare Facilities Suhail Ahmad * and Wadha Alfouzan Department of Microbiology, Faculty of Medicine, Kuwait University, P.O. Box 24923, Safat 13110, Kuwait; [email protected] * Correspondence: [email protected]; Tel.: +965-2463-6503 Abstract: Candida auris, a recently recognized, often multidrug-resistant yeast, has become a sig- nificant fungal pathogen due to its ability to cause invasive infections and outbreaks in healthcare facilities which have been difficult to control and treat. The extraordinary abilities of C. auris to easily contaminate the environment around colonized patients and persist for long periods have recently re- sulted in major outbreaks in many countries. C. auris resists elimination by robust cleaning and other decontamination procedures, likely due to the formation of ‘dry’ biofilms. Susceptible hospitalized patients, particularly those with multiple comorbidities in intensive care settings, acquire C. auris rather easily from close contact with C. auris-infected patients, their environment, or the equipment used on colonized patients, often with fatal consequences. This review highlights the lessons learned from recent studies on the epidemiology, diagnosis, pathogenesis, susceptibility, and molecular basis of resistance to antifungal drugs and infection control measures to combat the spread of C. auris Citation: Ahmad, S.; Alfouzan, W. Candida auris: Epidemiology, infections in healthcare facilities. Particular emphasis is given to interventions aiming to prevent new Diagnosis, Pathogenesis, Antifungal infections in healthcare facilities, including the screening of susceptible patients for colonization; the Susceptibility, and Infection Control cleaning and decontamination of the environment, equipment, and colonized patients; and successful Measures to Combat the Spread of approaches to identify and treat infected patients, particularly during outbreaks.
    [Show full text]
  • Supplementary Materials
    Supplementary Materials C4Y5P9|C4Y5P9_CLAL4 ------------------MS-EDLTKKTE------ELSLDSEKTVLSSKEEFTAKHPLNS 35 Q9P975|IF4E_CANAL ------------------MS-EELAQKTE------ELSLDS-KTVFDSKEEFNAKHPLNS 34 Q6BXX3|Q6BXX3_DEBHA --MKVF------TNKIAKMS-EELSKQTE------ELSLENKDTVLSNKEEFTAKHPLNN 45 C5DJV3|C5DJV3_LACTC ------------------MSVEEVTQKTG-D-----LNIDEKSTVLSSEKEFQLKHPLNT 36 P07260|IF4E_YEAST ------------------MSVEEVSKKFE-ENVSVDDTTATPKTVLSDSAHFDVKHPLNT 41 I2JS39|I2JS39_DEKBR MQMNLVGRTFPASERTRQSREEKPVE----AEVAKPEEEKKDVTVLENKEEFTVKHPLNS 56 A0A099P1Q5|A0A099P1Q5_PICKU ------------------MSTEELNN----ATKDLSLDEKKDVTALENPAEFNVKHPLNS 38 P78954|IF4E1_SCHPO ------------------MQTEQPPKESQTENTVSEPQEKALRTVFDDKINFNLKHPLAR 42 *. : *.:.. .* **** C4Y5P9|C4Y5P9_CLAL4 KWTLWYTKPQTNKSETWSDLLKPVITFSSVEEFWGIYNSIPVANQLPMKSDYHLFKEGIK 95 Q9P975|IF4E_CANAL RWTLWYTKPQTNKSENWHDLLKPVITFSSVEEFWGIYNSIPPANQLPLKSDYHLFKEGIR 94 Q6BXX3|Q6BXX3_DEBHA KWTLWYTKPQVNKSENWHDLLKPVITFSSVEEFWGIYNSIPQANQLPMKSDYHLFKEGIK 105 C5DJV3|C5DJV3_LACTC KWTLWYTKPPVDKSESWSDLLRPVTSFETVEEFWAIHNAIPKPRYLPLKSDYHLFRNDIR 96 P07260|IF4E_YEAST KWTLWYTKPAVDKSESWSDLLRPVTSFQTVEEFWAIIQNIPEPHELPLKSDYHVFRNDVR 101 I2JS39|I2JS39_DEKBR KWTLWYTKPAVDKNESWADLLKPIVSFDTVEEFWGIYHAVPKAVDLPLKSDYHLFRNDIK 116 A0A099P1Q5|A0A099P1Q5_PICKU TWTLWYTKPAVDNTESWADLLKPVVTFNTVEEFWGIFHAIPKVNELPLKSDYHLFRGDIK 98 P78954|IF4E1_SCHPO PWTLWFLMPPTPG-LEWNELQKNIITFNSVEEFWGIHNNINPASSLPIKSDYSFFREGVR 101 ****: * . * :* : : :*.:*****.* : : **:**** .*: .:: C4Y5P9|C4Y5P9_CLAL4 PEWEDEQNAKGGRWQYSFNNKRDVAQVINDLWLRGLLAVIGETIEDD---ENEVNGIVLN 152 Q9P975|IF4E_CANAL PEWEDEANSKGGKWQFSFNKKSEVNPIINDLWLRGLLAVIGETIEDE---ENEVNGIVLN
    [Show full text]
  • Candida Species Identification by NAA
    Candida Species Identification by NAA Background Vulvovaginal candidiasis (VVC) occurs as a result of displacement of the normal vaginal flora by species of the fungal genus Candida, predominantly Candida albicans. The usual presentation is irritation, itching, burning with urination, and thick, whitish discharge.1 VVC accounts for about 17% to 39% of vaginitis1, and most women will be diagnosed with VVC at least once during their childbearing years.2 In simplistic terms, VVC can be classified into uncomplicated or complicated presentations. Uncomplicated VVC is characterized by infrequent symptomatic episodes, mild to moderate symptoms, or C albicans infection occurring in nonpregnant and immunocompetent women.1 Complicated VVC, in contrast, is typified by severe symptoms, frequent recurrence, infection with Candida species other than C albicans, and/or occurrence during pregnancy or in women with immunosuppression or other medical conditions.1 Diagnosis and Treatment of VVC Traditional diagnosis of VVC is accomplished by either: (i) direct microscopic visualization of yeast-like cells with or without pseudohyphae; or (ii) isolation of Candida species by culture from a vaginal sample.1 Direct microscopy sensitivity is about 50%1 and does not provide a species identification, while cultures can have long turnaround times. Today, nucleic acid amplification-based (NAA) tests (eg, PCR) for Candida species can provide high-quality diagnostic information with quicker turnaround times and can also enable investigation of common potential etiologies
    [Show full text]
  • Saccharomyces Eubayanus, the Missing Link to Lager Beer Yeasts
    MICROBE PROFILE Sampaio, Microbiology 2018;164:1069–1071 DOI 10.1099/mic.0.000677 Microbe Profile: Saccharomyces eubayanus, the missing link to lager beer yeasts Jose Paulo Sampaio* Graphical abstract Ecology and phylogeny of Saccharomyces eubayanus. (a) The ecological niche of S. eubayanus in the Southern Hemisphere – Nothofagus spp. (southern beech) and sugar-rich fructifications (stromata) of its fungal biotrophic parasite Cyttaria spp., that can attain the size of golf balls. (b) Schematic representation of the phylogenetic position of S. eubayanus within the genus Saccharomyces based on whole-genome sequences. Occurrence in natural environments (wild) or participation in different human-driven fermentations is highlighted, together with the thermotolerant or cold-tolerant nature of each species and the origins of S. pastorianus, the lager beer hybrid. Abstract Saccharomyces eubayanus was described less than 10 years ago and its discovery settled the long-lasting debate on the origins of the cold-tolerant yeast responsible for lager beer fermentation. The largest share of the genetic diversity of S. eubayanus is located in South America, and strains of this species have not yet been found in Europe. One or more hybridization events between S. eubayanus and S. cerevisiae ale beer strains gave rise to S. pastorianus, the allopolyploid yeasts responsible for lager beer production worldwide. The identification of the missing progenitor of lager yeast opened new avenues for brewing yeast research. It allowed not only the selective breeding of new lager strains, but revealed also a wild yeast with interesting brewing abilities so that a beer solely fermented by S. eubayanus is currently on the market.
    [Show full text]
  • Three New Species of B Otryotinia on Ranunculaceae1
    THREE NEW SPECIES OF B OTRYOTINIA ON RANUNCULACEAE1 G. L. HENNEBERT2 Institut agronomique, Universite de Louvain, Hervelee, Belgium AND J. W. GROVES3 Research Branch, Department of Agriculture, Ottawa, Canada Received October 10, 1962 Abstract Three new species of Botryotinia on Caltha palustris L., Ranunculus septen- trionalis Poir., and Ficaria verna Huds. (Ranunculaceae) are described as B. calthae Hennebert and Elliott, B. ranunculi Hennebert and Groves, and B. ficariarum Hennebert. Each of the three species has a Botrytis state of the 73. cinerea complex, and they thus constitute additions to the species already segregated from that complex, i.e. Botryotinia fuckeliana, 73. convoluta, B. draytoni, and B. pelargonii. The Botrytis state of B. ficariarum can be distinguished morp­ hologically. While B. ranunculi is a North American species and B. ficariarum an European one, B. calthae is reported from both continents. Introduction Botryotinia, a genus of the Sclerotiniaceae, was erected by Whetzel (1945) for four species formerly assigned to Sclerotinia Fuckel, but which differ from the true Sclerotinia species mainly in their erumpent, planoconvexoid sclerotia which are firmly attached to the substrate, and in the possession of a conidial state belonging to the form-genus Botrytis Pers. The type species is Botryotinia convoluta (Drayton) Whetzel in which the conidial state is a Botrytis of the cinerea type or B. cinerea sensu lato, and the other species included were Botryotinia fuckeliana (De Bary) Whetzel, of which the conidial state is Botrytis cinerea Pers. or B. cinerea sensu stricto, and Botryotinia ricini (Godfrey) Whetz. and B. porri (v. Beyma) Whetz. In the latter two species the conidial states would not be considered Botrytis species of the cinerea type.
    [Show full text]
  • Isolation and Characterization of Botrytis Antigen from Allium Cepa L. and Its Role in Rapid Diagnosis of Neck Rot
    International Journal of Research and Scientific Innovation (IJRSI) |Volume VIII, Issue V, May 2021|ISSN 2321-2705 Isolation and characterization of Botrytis antigen from Allium cepa L. and its role in rapid diagnosis of neck rot Prabin Kumar Sahoo1, Amrita Masanta2, K. Gopinath Achary3, Shikha Singh4* 1,2,4 Rama Devi Women’s University, Vidya Vihar, Bhubaneswar, Odisha, India 3Imgenex India Pvt. Ltd, E-5 Infocity, Bhubaneswar, Odisha, India Corresponding author* Abstract: Early and accurate diagnosis of neckrot in onions and B. aclada are the predominant species reported to cause permits early treatment which can enhance yield and its storage. neck rot of onion, these species are difficult to distinguish In the present study, polyclonal antibody (pAb) raised against morphologically because of similar growth patterns on agar the protein extract from Botrytis allii was established for the media, and overlapping spore sizes [4]. detection of neck rot using serological assays. The pathogenic proteins were recognized by ELISA with high sensitivity (50 ng). Recent studies of the ribosomal internal transcribed spacer Correlation coefficient between infected onions from different (ITS) region of the genome of Botrytis spp. associated with stages and from different agroclimatic zones with antibody titres neck rot of onion have confirmed the existence of three was taken as the primary endpoint for standardization of the distinct groups [5]. These include a smaller-spored group with protocol. Highest positive correlation (r ¼ 0.999) was observed in 16 mitotic chromosomes, (B. aclada AI), a larger-spored stage I and II infected samples of North-western zone, whereas low negative correlation (r ¼ _0.184) was found in stage III group with 16 mitotic chromosomes (B.
    [Show full text]
  • Plant Life Magill’S Encyclopedia of Science
    MAGILLS ENCYCLOPEDIA OF SCIENCE PLANT LIFE MAGILLS ENCYCLOPEDIA OF SCIENCE PLANT LIFE Volume 4 Sustainable Forestry–Zygomycetes Indexes Editor Bryan D. Ness, Ph.D. Pacific Union College, Department of Biology Project Editor Christina J. Moose Salem Press, Inc. Pasadena, California Hackensack, New Jersey Editor in Chief: Dawn P. Dawson Managing Editor: Christina J. Moose Photograph Editor: Philip Bader Manuscript Editor: Elizabeth Ferry Slocum Production Editor: Joyce I. Buchea Assistant Editor: Andrea E. Miller Page Design and Graphics: James Hutson Research Supervisor: Jeffry Jensen Layout: William Zimmerman Acquisitions Editor: Mark Rehn Illustrator: Kimberly L. Dawson Kurnizki Copyright © 2003, by Salem Press, Inc. All rights in this book are reserved. No part of this work may be used or reproduced in any manner what- soever or transmitted in any form or by any means, electronic or mechanical, including photocopy,recording, or any information storage and retrieval system, without written permission from the copyright owner except in the case of brief quotations embodied in critical articles and reviews. For information address the publisher, Salem Press, Inc., P.O. Box 50062, Pasadena, California 91115. Some of the updated and revised essays in this work originally appeared in Magill’s Survey of Science: Life Science (1991), Magill’s Survey of Science: Life Science, Supplement (1998), Natural Resources (1998), Encyclopedia of Genetics (1999), Encyclopedia of Environmental Issues (2000), World Geography (2001), and Earth Science (2001). ∞ The paper used in these volumes conforms to the American National Standard for Permanence of Paper for Printed Library Materials, Z39.48-1992 (R1997). Library of Congress Cataloging-in-Publication Data Magill’s encyclopedia of science : plant life / edited by Bryan D.
    [Show full text]